Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Nanoparticle transport across the blood brain barrier.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Pathogenic implications of iron accumulation in multiple sclerosis.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Combination therapy of interferon Beta-1b and tacrolimus: a pilot safety study.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Berlex continues legal challenge to FDA over MS drug.
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
Multiple Sclerosis.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.

Pages